Zhongsheng Peng

发表论文 55 篇 · 总被引 23 次 · h-index 3

代表论文

Efficacy of immunotherapy in RET fusion-positive NSCLC: A meta-analysis (2024 · Heliyon · 被引 3)
Long-term survival case of SCLC transformation after Osimertinib resistance in EGFR-mutant NSCLC: Benefits from chemo-immunotherapy combined with anti-angiogenic therapy followed by Osimertinib rechallenge (2025 · Cancer Letters · 被引 2)
Figure S6 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts (2026)
Figure S4 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts (2026)
cohort1-47 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts (2026)
Figure S5 from Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts (2026)